These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 14990343)
1. Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra. Galazka-Friedman J; Bauminger ER; Koziorowski D; Friedman A Biochim Biophys Acta; 2004 Mar; 1688(2):130-6. PubMed ID: 14990343 [TBL] [Abstract][Full Text] [Related]
2. Iron and ferritin in hippocampal cortex and substantia nigra in human brain--implications for the possible role of iron in dementia. Friedman A; Galazka-Friedman J; Bauminger ER; Koziorowski D J Neurol Sci; 2006 Oct; 248(1-2):31-4. PubMed ID: 16797029 [TBL] [Abstract][Full Text] [Related]
3. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. Koziorowski D; Friedman A; Arosio P; Santambrogio P; Dziewulska D Parkinsonism Relat Disord; 2007 May; 13(4):214-8. PubMed ID: 17275395 [TBL] [Abstract][Full Text] [Related]
4. Iron in parkinsonian and control substantia nigra--a Mössbauer spectroscopy study. Gałazka-Friedman J; Bauminger ER; Friedman A; Barcikowska M; Hechel D; Nowik I Mov Disord; 1996 Jan; 11(1):8-16. PubMed ID: 8771061 [TBL] [Abstract][Full Text] [Related]
5. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424 [TBL] [Abstract][Full Text] [Related]
6. Iron as a cause of Parkinson disease - a myth or a well established hypothesis? Friedman A; Galazka-Friedman J; Koziorowski D Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S212-4. PubMed ID: 20082993 [TBL] [Abstract][Full Text] [Related]
7. [Mossbauer spectroscopy of iron in substantia nigra in Parkinson disease and controls]. Friedman A; Bauminger ER; Gałazka-Friedman J; Barcikowska M; Suwalski J; Hechel D; Dymecki J; Nowik I Neurol Neurochir Pol; 1994; 28(1 Suppl 1):145-55. PubMed ID: 8065540 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress. You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962 [TBL] [Abstract][Full Text] [Related]
9. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease. Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135 [TBL] [Abstract][Full Text] [Related]
11. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960 [TBL] [Abstract][Full Text] [Related]
12. Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra. Gerlach M; Trautwein AX; Zecca L; Youdim MB; Riederer P J Neurochem; 1995 Aug; 65(2):923-6. PubMed ID: 7616255 [TBL] [Abstract][Full Text] [Related]
13. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Felletschin B; Bauer P; Walter U; Behnke S; Spiegel J; Csoti I; Sommer U; Zeiler B; Becker G; Riess O; Berg D Neurosci Lett; 2003 Nov; 352(1):53-6. PubMed ID: 14615048 [TBL] [Abstract][Full Text] [Related]
14. The role of iron in neurodegeneration--Mössbauer spectroscopy, electron microscopy, enzyme-linked immunosorbent assay and neuroimaging studies. Galazka-Friedman J; Bauminger ER; Szlachta K; Friedman A J Phys Condens Matter; 2012 Jun; 24(24):244106. PubMed ID: 22595616 [TBL] [Abstract][Full Text] [Related]
15. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. Faucheux BA; Martin ME; Beaumont C; Hunot S; Hauw JJ; Agid Y; Hirsch EC J Neurochem; 2002 Oct; 83(2):320-30. PubMed ID: 12423242 [TBL] [Abstract][Full Text] [Related]
16. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073 [TBL] [Abstract][Full Text] [Related]
17. Controversies about iron in parkinsonian and control substantia nigra. Gałazka-Friedman J; Friedman A Acta Neurobiol Exp (Wars); 1997; 57(3):217-25. PubMed ID: 9407708 [TBL] [Abstract][Full Text] [Related]
18. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage. Berg D J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382 [TBL] [Abstract][Full Text] [Related]
19. Iron, the substantia nigra and related neurological disorders. Snyder AM; Connor JR Biochim Biophys Acta; 2009 Jul; 1790(7):606-14. PubMed ID: 18778755 [TBL] [Abstract][Full Text] [Related]
20. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Berg D; Grote C; Rausch WD; Mäurer M; Wesemann W; Riederer P; Becker G Ultrasound Med Biol; 1999 Jul; 25(6):901-4. PubMed ID: 10461717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]